| Protagenic Therapeutics, Inc.\new |
ex CEO, Director, 10%+ Owner |
Common Stock |
16.2K |
$67.2K |
$4.14 |
15 May 2025 |
These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. |
| APPlife Digital Solutions Inc |
CFO, Director, 10%+ Owner |
Common Stock |
500M |
|
|
13 Jun 2025 |
These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member. |
| APPlife Digital Solutions Inc |
CFO, Director, 10%+ Owner |
Common Stock |
50M |
|
|
13 Jun 2025 |
These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. |
| BLOOMIOS, INC. |
Pres, Chief Strategy Officer, Director, 10%+ Owner |
Common Stock |
2.59M |
|
|
09 Jul 2021 |
By AGPL |
| BLOOMIOS, INC. |
Pres, Chief Strategy Officer, Director, 10%+ Owner |
Common Stock |
1.26M |
|
|
09 Jul 2021 |
By MCC |
| BLOOMIOS, INC. |
Pres, Chief Strategy Officer, Director, 10%+ Owner |
Common Stock |
250K |
|
|
09 Jul 2021 |
By CE |
| Protagenic Therapeutics, Inc.\new |
ex CEO, Director, 10%+ Owner |
Preferred Stock Series C-1 |
131K |
|
|
15 May 2025 |
These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. |
| BLOOMIOS, INC. |
Pres, Chief Strategy Officer, Director, 10%+ Owner |
Common Stock |
100K |
|
|
09 Jul 2021 |
By TSP |
| BLOOMIOS, INC. |
Pres, Chief Strategy Officer, Director, 10%+ Owner |
Common Stock |
25K |
|
|
09 Jul 2021 |
By BSRS |
| Protagenic Therapeutics, Inc.\new |
ex CEO, Director, 10%+ Owner |
Preferred Stock Series D |
4.5K |
|
|
15 May 2025 |
These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. |
| APPlife Digital Solutions Inc |
CFO, Director, 10%+ Owner |
Preferred Stock Series C |
1.25K |
|
|
13 Jun 2025 |
These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member. |
| Protagenic Therapeutics, Inc.\new |
ex CEO, Director, 10%+ Owner |
Preferred Stock Series D |
1K |
|
|
15 May 2025 |
Direct |
| Protagenic Therapeutics, Inc.\new |
ex CEO, Director, 10%+ Owner |
Preferred Stock Series D |
1K |
|
|
15 May 2025 |
These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member. |
| Protagenic Therapeutics, Inc.\new |
ex CEO, Director, 10%+ Owner |
Preferred Stock Series C |
787 |
|
|
15 May 2025 |
These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member. |